BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19703559)

  • 1. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery.
    Shin SB; Cho HY; Kim DD; Choi HG; Lee YB
    Eur J Pharm Biopharm; 2010 Feb; 74(2):164-71. PubMed ID: 19703559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
    Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
    Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time.
    Xu W; Ling P; Zhang T
    Int J Pharm; 2014 Jan; 460(1-2):173-80. PubMed ID: 24172796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation.
    Fu YC; Fu TF; Wang HJ; Lin CW; Lee GH; Wu SC; Wang CK
    Acta Biomater; 2014 Nov; 10(11):4583-4596. PubMed ID: 25050775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
    Hu K; Shi Y; Jiang W; Han J; Huang S; Jiang X
    Int J Pharm; 2011 Aug; 415(1-2):273-83. PubMed ID: 21651967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus.
    Zhang D; Pan X; Wang S; Zhai Y; Guan J; Fu Q; Hao X; Qi W; Wang Y; Lian H; Liu X; Wang Y; Sun Y; He Z; Sun J
    Mol Pharm; 2015 Jul; 12(7):2337-51. PubMed ID: 26024817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of adriamycin from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles.
    Mo SM; Oh IJ
    J Nanosci Nanotechnol; 2011 Feb; 11(2):1795-8. PubMed ID: 21456294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of FK506-loaded PLGA nanoparticles prolongs cardiac allograft survival.
    Deng C; Chen Y; Zhang L; Wu Y; Li H; Wu Y; Wang B; Sun Z; Li Y; Lv Q; Yang Y; Wang J; Jin Q; Xie M
    Int J Pharm; 2020 Feb; 575():118951. PubMed ID: 31843550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation.
    Hu S; Zhang Y
    Int J Nanomedicine; 2010 Nov; 5():1039-48. PubMed ID: 21170352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
    Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
    Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.
    Zhang J; Li Y; Gao W; Repka MA; Wang Y; Chen M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1367-80. PubMed ID: 24935153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small angle neutron scattering studies on the internal structure of poly(lactide-co-glycolide)-block-poly(ethylene glycol) nanoparticles as drug delivery vehicles.
    Yang B; Lowe JP; Schweins R; Edler KJ
    Biomacromolecules; 2015 Feb; 16(2):457-64. PubMed ID: 25539145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus-loaded methoxy poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid micelles self-assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats.
    Liu D; Wu Q; Chen W; Lin H; Liu Y; Liang H; Zhu F
    Eur J Pharm Sci; 2019 May; 133():104-114. PubMed ID: 30928512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
    J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro-in vivo evaluation of surface-modified poly(lactide-co-glycolide) nanoparticles as controlled release carriers for flutamide delivery.
    Ige PP; Dipsingh SN
    J Microencapsul; 2015; 32(3):231-9. PubMed ID: 25539154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.